相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma
James S. Lally et al.
CELL METABOLISM (2019)
Acetyl-CoA carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis
Eric J. Lawitz et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis
Maria Apostolopoulou et al.
DIABETES CARE (2018)
Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents
Leigh Goedeke et al.
HEPATOLOGY (2018)
Lipotoxicity and the gut-liver axis in NASH pathogenesis
Fabio Marra et al.
JOURNAL OF HEPATOLOGY (2018)
GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease
Rohit Loomba et al.
GASTROENTEROLOGY (2018)
q2-longitudinal: Longitudinal and Paired-Sample Analyses of Microbiome Data
Nicholas A. Bokulich et al.
MSYSTEMS (2018)
Comprehensive Metabolomic and Lipidomic Profiling of Human Kidney Tissue: A Platform Comparison
Patrick Leuthold et al.
JOURNAL OF PROTEOME RESEARCH (2017)
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
Anna M. Diehl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus
Cristina Llorente et al.
NATURE COMMUNICATIONS (2017)
Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation (vol 26, pg 394, 2017)
Chai-Wan Kim et al.
CELL METABOLISM (2017)
The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease
Jelske N. van der Veen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2017)
Design, synthesis and biological evaluation of dihydroquinoxalinone derivatives as BRD4 inhibitors
Yifei Yang et al.
BIOORGANIC CHEMISTRY (2016)
Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation
Lirui Wang et al.
CELL HOST & MICROBE (2016)
The Severity of Nonalcoholic Fatty Liver Disease Is Associated With Gut Dysbiosis and Shift in the Metabolic Function of the Gut Microbiota
Jerome Boursier et al.
HEPATOLOGY (2016)
Plasma Lipidomics Investigation of Hemodialysis Effects by Using Liquid Chromatography-Mass Spectrometry
Lichao Wang et al.
JOURNAL OF PROTEOME RESEARCH (2016)
Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models
Robert U. Svensson et al.
NATURE MEDICINE (2016)
Nonalcoholic steatohepatitis (NASH) drugs market
Sorcha Cassidy et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
Giovanni Musso et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
The role of the gut microbiota in NAFLD
Christopher Leung et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats
Geraldine Harriman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Discovery of spirocyclic-diamine inhibitors of mammalian acetyl CoA-carboxylase
Daniel W. Kung et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice
Magdalena Mazagova et al.
FASEB JOURNAL (2015)
Crystal structure of the 500-kDa yeast acetyl-CoA carboxylase holoenzyme dimer
Jia Wei et al.
NATURE (2015)
Recent Advances in the Development of Acetyl-CoA Carboxylase (ACC) Inhibitors for the Treatment of Metabolic Disease
Matthew P. Bourbeau et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Decreasing the Rate of Metabolic Ketone Reduction in the Discovery of a Clinical Acetyl-CoA Carboxylase Inhibitor for the Treatment of Diabetes
David A. Griffith et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Liver fibrosis and repair: immune regulation of wound healing in a solid organ
Antonella Pellicoro et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Characterization of Gut Microbiomes in Nonalcoholic Steatohepatitis (NASH) Patients: A Connection Between Endogenous Alcohol and NASH
Lixin Zhu et al.
HEPATOLOGY (2013)
Global metabolic profiling of animal and human tissues via UPLC-MS
Elizabeth J. Want et al.
NATURE PROTOCOLS (2013)
High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice
Hiroyuki Tsuchiya et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Phylotype-level 16S rRNA analysis reveals new bacterial indicators of health state in acute murine colitis
David Berry et al.
ISME JOURNAL (2012)
Fatty acid metabolism: target for metabolic syndrome
Salih J. Wakil et al.
JOURNAL OF LIPID RESEARCH (2009)
A lipidomic analysis of nonalcoholic fatty liver disease
Puneet Puri et al.
HEPATOLOGY (2007)
LIPID MAPS online tools for lipid research
Eoin Fahy et al.
NUCLEIC ACIDS RESEARCH (2007)
Acetyl-coenzyme A carboxylases: Versatile targets for drug discovery
Liang Tong et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis
Zhaoyu Li et al.
CELL METABOLISM (2006)
Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: Impact on disease progression
Y Ikura et al.
HEPATOLOGY (2006)
Fatty acid flux suppresses fatty acid synthesis in hamster intestine independently of SREBP-1 expression
FJ Field et al.
JOURNAL OF LIPID RESEARCH (2003)
The subcellular localization of acetyl-CoA carboxylase 2
L Abu-Elheiga et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
